Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 226 AL 240

Effect and mechanism of acupuncture on Alzheimer's disease

Zeng BY, Salvage S, Jenner P.

Int Rev Neurobiol. 2013;111:181-95. doi: 10.1016/B978-0-12-411545-3.00009-2.

Alzheimer disease therapy--moving from amyloid-β to tau

Giacobini E, Gold G.

Nat Rev Neurol. 2013 Dec;9(12):677-86. doi: 10.1038/nrneurol.2013.223. Epub 2013 Nov 12.

ω-3 fatty acids in the prevention of cognitive decline in humans

Cederholm T, Salem N Jr, Palmblad J.

Adv Nutr. 2013 Nov 6;4(6):672-6. doi: 10.3945/an.113.004556. eCollection 2013 Nov.

Connecting type 2 diabetes to Alzheimer's disease

De Felice FG.

Expert Rev Neurother. 2013 Dec;13(12):1297-9. doi: 10.1586/14737175.2013.864824.

Natural products for Alzheimer's disease therapy: basic and application

Xiao J, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1679-80. doi: 10.1111/jphp.12186.

Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment

Pinho BR, Ferreres F, Valentão P, Andrade PB.

J Pharm Pharmacol. 2013 Dec;65(12):1681-700. doi: 10.1111/jphp.12081. Epub 2013 May 16.

Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease

Konrath EL, Passos Cdos S, Klein LC Jr, Henriques AT.

J Pharm Pharmacol. 2013 Dec;65(12):1701-25. doi: 10.1111/jphp.12090. Epub 2013 Jun 20.

Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity

Bonesi M, Loizzo MR, Conforti F, Passalacqua NG, Saab A, Menichini F, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1726-35. doi: 10.1111/jphp.12172. Epub 2013 Nov 6.

Alzheimer's as a metabolic disease

Demetrius LA, Driver J.

Biogerontology. 2013 Dec;14(6):641-9. doi: 10.1007/s10522-013-9479-7. Epub 2013 Nov 19.

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R.

Drug Des Devel Ther. 2013 Nov 13;7:1359-64. doi: 10.2147/DDDT.S53401. eCollection 2013.

Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime

McBrayer M, Nixon RA.

Biochem Soc Trans. 2013 Dec;41(6):1495-502. doi: 10.1042/BST20130201.

Endocannabinoid signalling in Alzheimer's disease

Maroof N, Pardon MC, Kendall DA.

Biochem Soc Trans. 2013 Dec;41(6):1583-7. doi: 10.1042/BST20130140.

Drosophila melanogaster as a model organism for Alzheimer's disease

Prüßing K, Voigt A, Schulz JB.

Mol Neurodegener. 2013 Nov 22;8:35. doi: 10.1186/1750-1326-8-35.

Dance with me

Aka S.

Can Nurse. 2013 Oct;109(8):30-1.

[Present and future of the tau dementia therapy]

Takashima A.

Rinsho Shinkeigaku. 2013;53(11):1040-2. doi: 10.5692/clinicalneurol.53.1040.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias